 Cost effectiveness low-dose zidovudine therapy asymptomatic patients human immunodeficiency virus HIV infection cost-effectiveness analysis zidovudine therapy asymptomatic patients human immunodeficiency virus HIV infection incremental direct medical costs zidovudine therapy data effects therapy report Acquired Immunodeficiency Syndrome AIDS Clinical Trials Group Protocol Zidovudine therapy annual incremental cost person cost year life ranges epidemiologic model potential long-term zidovudine effect sensitivity analyses cost year life ranges expensive zidovudine therapy potential substantial survival benefit patients cost effectiveness zidovudine therapy common medical therapies